ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 92 filers reported holding ALLOVIR INC in Q3 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,000 | +20.0% | 8,547 | +95.4% | 0.00% | – |
| Q2 2023 | $15,000 | +87.5% | 4,374 | +107.7% | 0.00% | – |
| Q1 2023 | $8,000 | -55.6% | 2,106 | -40.8% | 0.00% | – |
| Q4 2022 | $18,000 | +500.0% | 3,555 | +833.1% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 381 | -19.8% | 0.00% | – |
| Q2 2022 | $2,000 | -85.7% | 475 | -77.5% | 0.00% | – |
| Q1 2022 | $14,000 | -83.5% | 2,112 | -67.8% | 0.00% | – |
| Q4 2021 | $85,000 | +16.4% | 6,559 | +126.2% | 0.00% | – |
| Q3 2021 | $73,000 | +52.1% | 2,900 | +17.3% | 0.00% | – |
| Q2 2021 | $48,000 | -14.3% | 2,472 | +4.7% | 0.00% | – |
| Q1 2021 | $56,000 | +124.0% | 2,362 | +260.6% | 0.00% | – |
| Q4 2020 | $25,000 | -94.3% | 655 | -95.9% | 0.00% | – |
| Q3 2020 | $436,000 | – | 15,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |